f-chemotactic peptide has been researched along with piroxicam in 1 studies
| Studies (f-chemotactic peptide) | Trials (f-chemotactic peptide) | Recent Studies (post-2010) (f-chemotactic peptide) | Studies (piroxicam) | Trials (piroxicam) | Recent Studies (post-2010) (piroxicam) |
|---|---|---|---|---|---|
| 79 | 0 | 4 | 3,084 | 796 | 704 |
| Protein | Taxonomy | f-chemotactic peptide (IC50) | piroxicam (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.3043 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.1 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bylund, J; Dahlgren, C; Fu, H; Karlsson, J; Stenfeldt, AL; Wennerås, C | 1 |
1 other study(ies) available for f-chemotactic peptide and piroxicam
| Article | Year |
|---|---|
The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Humans; Ligands; Neutrophils; Oligopeptides; Piroxicam; Protein Binding; Receptors, Formyl Peptide; Receptors, Lipoxin; Superoxides | 2007 |